FBR Capital Reiterates Outperform on Centene (CNC) Following 2Q Beat and Raise

Go back to FBR Capital Reiterates Outperform on Centene (CNC) Following 2Q Beat and Raise

Jefferies Cuts Price Target on Centene (CNC) to $82 Following 2Q EPS Beat

July 27, 2016 8:25 AM EDT

Jefferies maintained a Buy rating on Centene (NYSE: CNC), and cut the price target to $82.00 (from $89.00), following the company's 2Q earnings report. Adjusted EPS of $1.29 was $0.20 above consensus and included 19c of Exchange true-ups.

Analyst David Windley commented, "The PDR and reserve... More

Centene (CNC) Tops Q2 EPS by 20c; Updates FY16 Outlook

July 26, 2016 6:11 AM EDT

Centene (NYSE: CNC) reported Q2 EPS of $1.29, $0.20 better than the analyst estimate of $1.09. Revenue for the quarter came in at $10.9 billion versus the consensus estimate of $10.79 billion.

GUIDANCE:

Centene sees FY2016 EPS of $4.20-$4.55, versus the consensus of $4.21. Centene sees... More

Trading Radar for 7/26: Apple (AAPL), McDonald's (MCD), 3M (MMM), Caterpillar (CAT), Verizon (VZ), [Conference Call] Under Armour (UA) Report

July 25, 2016 2:40 PM EDT

AThe Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
9:00am EDT

Case-Shiller 20-city Index - Street sees 5.4%

Earnings:

3M Co. (NYSE: MMM) - consensus EPS $2.07
A.O. Smith (NYSE: AOS) - consensus EPS $0.91
AK Steel (NYSE: AKS) - consensus loss $0.04
Accuride (NYSE: ACW) - consensus EPS $0.04
Allegheny Technologies (NYSE: ATI) - consensus loss... More

U.S. government's bid to block insurance mergers could spawn new ones

July 22, 2016 7:24 PM EDT

By Carl O'Donnell and Caroline Humer

(Reuters) - The potential bust-up of two mega deals among Americas largest health insurance companies may have an unintended result - more mergers.

The U.S. Department of Justice on Thursday sued to block Aetna Inc's (NYSE: AET) $37 billion purchase of Humana Inc (NYSE: HUM) and Anthem Incs (NYSE: ANTM) proposed $54 billion buyout of Cigna Corp (NYSE: CI), arguing that they would cut competition and boost rates... More